期刊文献+

抗核抗体与EB病毒抗体水平的关系 被引量:3

Relationship between the levels of anti-nuclear antibodies and Epstein-Barr virus antibodies
下载PDF
导出
摘要 目的探讨EB病毒(EBV)特异性抗体对抗核抗体(ANA)阳性患者和ANA阴性健康对照者的免疫反应。方法采用间接免疫荧光法检测ANA,采用免疫印迹法检测抗可提取性核抗原(ENA)抗体,采用酶联免疫吸附试验(ELISA)检测80例ANA阳性患者和48名体检健康者血清EBV-衣壳抗原(VCA)Ig M、EBV-VCA Ig G、EBV-早期抗原(EA)Ig G和EBV核抗原(EBNA-1)Ig G水平,比较ANA阳性患者与ANA阴性健康对照者的EBV抗体阳性率、EBV抗体水平差异,分析ANA阳性患者EBV抗体水平与ENA抗体种类、个数之间的关系。结果 ANA阳性组血清EBV-VCA Ig G、EBV-EA Ig G和EBNA-1 Ig G水平较健康对照组明显升高(P<0.01),且EBV-EA Ig G阳性率明显高于健康对照组(χ~2=5.747,P=0.017)。抗ENA抗体谱中,抗SS-A/Ro抗体、抗SS-B/La抗体阳性组分别与抗SS-A/Ro抗体、抗SS-B/La抗体阴性组比较EBNA-1 Ig G水平明显升高(Z=-2.630,P=0.008;Z=-2.515,P=0.011),EBV-VCA Ig G和EBV-EA Ig G水平差异无统计学意义(P>0.05)。抗核小体抗体阳性组与抗核小体抗体阴性组比较EBV-VCA Ig G、EBV-EA Ig G水平明显升高(Z=-2.355,P=0.018;Z=-2.017,P=0.043),但2组之间EBNA-1 Ig G水平差异无统计学意义(P>0.05)。抗ENA抗体谱中自身抗体阳性个数不同的ANA阳性患者EBV-EA Ig G水平不同(χ~2=11.380,P=0.023)。结论EBV复发感染在ANA的产生中起重要作用。 ObjectiveTo evaluate the specific antibody immune response against Epstein-Barr virus (EBV)in patients with anti-nuclear antibody (ANA) positivity and negativity. MethodsANA was determined by indirectimmunofluorescence. Anti-extractable nuclear antigen (ENA) antibodies were determined by immunoblotting.Serum EBV-virus capsid antigen(VCA) IgM,EBV-VCA IgG,EBV-early antigen(EA) IgG and EBV nuclearantigen(EBNA-1) IgG levels were determined by enzyme-linked immunosorbent assay(ELISA) in 80 patientswith ANA positivity and 48 healthy subjects. The difference of EBV antibody positive rates and levels was evaluatedin ANA-positive patients in comparison with those in ANA-negative healthy controls. The relationship between EBVantibody level and the types and numbers of ENA antibodies was analyzed. ResultsEBV-VCA IgG,EBV-EA IgGand EBNA-1 IgG levels were higher in ANA-positive patients than those in healthy controls (P〈0.01),and ANApositivepatients showed a higher EBV-EA IgG positive rate compared to healthy controls(χ2=5.747,P=0.017).Furthermore,elevated EBNA-1 IgG was found in anti-SS-A/Ro antibody positive and anti-SS-B/La antibodypositive groups compared to those in anti-SS-A/Ro antibody negative and anti-SS-B/La antibody negative groups(Z=-2.630,P=0.008;Z=-2.515,P=0.011). EBV-VCA IgG and EBV-EA IgG levels had no statistical significance(P〉0.05). EBV-VCA IgG and EBV-EA IgG were higher in anti-nucleosome antibody positive group than thosein anti-nucleosome antibody negative group (Z=-2.355,P=0.018;Z=-2.017,P=0.043),while there was nostatistical significance for EBNA-1 IgG (P〉0.05). There was difference in the number of anti-ENA antibodies andthe distribution of EBV-EA IgG levels (χ2=11.380,P=0.023). ConclusionsEBV reactivation might be correlatedwith the presence of ANA.
作者 张敏杰 高玉芳 ZHANGMinjie;GAO Yufang.(Xianyang Central Hospital,Xianyang 712000,Shaanxi,China)
机构地区 咸阳市中心医院
出处 《检验医学》 CAS 2018年第5期416-420,共5页 Laboratory Medicine
关键词 抗核抗体 EB病毒 自身免疫 Anti-nuclear antibody Epstein-Barr virus Autoimmunity
  • 相关文献

参考文献5

二级参考文献16

  • 1Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLE: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35: 630-640.
  • 2Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum, 1988, 31:315-324.
  • 3Lopez-Hoyos M, Cabeza R. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunoiluorescence assay in patients with system/c lupus erythematosus. Lupus, 2005, 14:505-509.
  • 4Shmerling R H. Autoantibodies in systemic lupus erythematosus there before you know it[J]. N Engl J Med,2003,349(16) :1499-1500.
  • 5Nossent H, Rekvig O P. Antinuclear antibody screening in this new millennium: farewell to the microscope? [ J]. Scand J Rheumatol, 2001,30(3) :123-128.
  • 6Min D J, Kim S J, Pank S H, et al. Anti-nucleosome antibody : significance in lupus patients lacking anti-stranded DNA antibody[ J]. Ckin Exp Rheumatol,2002,20( 1 ) : 13 -18.
  • 7Cairns A P,McMillan S A,Croekard A D. et al. Antinueleosome antibodies in the diagnosis of systemic lupus erythematosus [ J ]. Ann Rheum Dis,2003,62 ( 3 ) :272 -273.
  • 8Benucci M,Gobbi F L,del Rosso A,et al. Disease activity and antinucleosome antibodies in systemic lupus erythematosus [ J ]. Scand J Rheumatol,2003,32( 1 ) :42-45.
  • 9Manfred-Wieser G,Pohla-Gubo H. Antinuclear antibodies (ANA) diagnostic value of different methods for screening and differentiation [J]. Clin Appl Immunol Rev,2001,1 (3) :201-206.
  • 10JIN Ying-kang,XIE Zheng-de,YANG Shuang,LU Gen,SHEN Kun-ling.Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China[J].Chinese Medical Journal,2010(11):1426-1430. 被引量:30

共引文献19

同被引文献40

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部